Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Bryophyllum Pinnatum for Nocturia
NCT04480658Completed
- Sponsor
- University of Zurich
- Start
- Jan 2018
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Bryophyllum pinnatum in nocturia, overactive bladder (OAB) and sleep disorder, sponsored by University of Zurich. Primary endpoints: Reduction of nocturia frequency at 4 weeks and Sleep-Quality at 4 weeks. Started Jan 2018; status: completed.
02
Drugs
Bryophyllum pinnatum
03
Conditions
nocturiaoveractive bladder (OAB)sleep disorder
Beyond the preview
Go deeper on NCT04480658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04480658.